NO20001403L - Substituerte kromanderivater - Google Patents

Substituerte kromanderivater

Info

Publication number: NO20001403L
Authority: NO; Norway
Prior art keywords: alkyl; substituted; conr; enantiomers; cycloalkyl
Prior art date: 1997-09-18

Application number

NO20001403A

Other languages

English (en)

Norwegian (no)

Other versions

NO20001403D0 (no

Inventor

Stefan Berg

Mats Torbjoern Linderberg

Svante Ross

Seth-Olov Thorberg

Bengt Ulff

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-18

Filing date

2000-03-17

Publication date

2000-05-18

2000-03-17 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2000-03-17 Publication of NO20001403D0 publication Critical patent/NO20001403D0/no

2000-05-18 Publication of NO20001403L publication Critical patent/NO20001403L/no

Links

VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical class [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 title 1
125000003118 aryl group Chemical group 0.000 abstract 2
229910052799 carbon Inorganic materials 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
125000005842 heteroatom Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
IBDPRZBVHRRHNT-UHFFFAOYSA-N 2h-chromene-3,4-diol Chemical class C1=CC=C2OCC(O)=C(O)C2=C1 IBDPRZBVHRRHNT-UHFFFAOYSA-N 0.000 abstract 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
239000012458 free base Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000004193 piperazinyl group Chemical group 0.000 abstract 1
125000003386 piperidinyl group Chemical group 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Psychology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Reproductive Health (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Rheumatology (AREA)
Nutrition Science (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO20001403A 1997-09-18 2000-03-17 Substituerte kromanderivater NO20001403L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9703378A SE9703378D0 (sv)	1997-09-18	1997-09-18	New compounds
PCT/SE1998/001604 WO1999014213A1 (fr)	1997-09-18	1998-09-09	Derives de chromane substitue

Publications (2)

Publication Number	Publication Date
NO20001403D0 NO20001403D0 (no)	2000-03-17
NO20001403L true NO20001403L (no)	2000-05-18

Family

ID=20408298

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001403A NO20001403L (no)	1997-09-18	2000-03-17	Substituerte kromanderivater

Country Status (23)

Country	Link
US (2)	US6387899B1 (fr)
EP (1)	EP1025096B1 (fr)
JP (1)	JP4002392B2 (fr)
KR (1)	KR20010024078A (fr)
CN (1)	CN1278809A (fr)
AR (1)	AR016651A1 (fr)
AT (1)	ATE255099T1 (fr)
AU (1)	AU9193398A (fr)
BR (1)	BR9812239A (fr)
CA (1)	CA2303926A1 (fr)
DE (1)	DE69820103T2 (fr)
EE (1)	EE200000144A (fr)
HR (1)	HRP20000133A2 (fr)
HU (1)	HUP0100276A3 (fr)
IL (1)	IL135074A0 (fr)
IS (1)	IS5403A (fr)
NO (1)	NO20001403L (fr)
PL (1)	PL339661A1 (fr)
SE (1)	SE9703378D0 (fr)
SK (1)	SK2872000A3 (fr)
TR (1)	TR200000737T2 (fr)
WO (1)	WO1999014213A1 (fr)
ZA (1)	ZA987806B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9703377D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	New compounds
CA2433950A1 (fr)	2001-01-16	2002-07-18	Timothy Davenport	Composes de chromone therapeutiques
MXPA03006261A (es) *	2001-01-16	2003-09-22	Astrazeneca Ab	Compuestos terapeuticos de cromano.
EP1353913A2 (fr)	2001-01-16	2003-10-22	AstraZeneca AB	Composes heterocycliques therapeutiques
WO2002066454A1 (fr) *	2001-02-21	2002-08-29	Sankyo Company, Limited	Derives de chromene
DK1408976T5 (da) *	2001-07-20	2011-01-10	Psychogenics Inc	Behandling af ADHD (Attention deficit hyperactivity disorder)
GB0124020D0 (en) *	2001-10-05	2001-11-28	Astrazeneca Ab	Chemical compounds
ITTO20030140U1 (it) *	2003-09-16	2005-03-17	Interfila Srl	Matita cosmetica
US20050065099A1 (en)	2003-09-19	2005-03-24	Gail Walkinshaw	Treatment of mitochondrial diseases
US20050165025A1 (en) *	2004-01-22	2005-07-28	Recordati Ireland Ltd.	Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
TWI346109B (en) *	2004-04-30	2011-08-01	Otsuka Pharma Co Ltd	4-amino-5-cyanopyrimidine derivatives
KR100681453B1 (ko) *	2005-03-22	2007-02-12	태남자동화기기 주식회사	권종 분류 기능을 구비한 지폐 방출기
US9066903B2 (en)	2006-02-28	2015-06-30	The United States Of America As Represented By The Department Of Veterans Affairs	Pharmacological treatment of Parkinson's disease
WO2008130319A2 (fr) *	2007-04-23	2008-10-30	Astrazeneca Ab	Nouveaux composés 805
WO2008130323A1 (fr) *	2007-04-23	2008-10-30	Astrazeneca Ab	Nouveaux dérivés 8-pipérazine-tétrahydronaphtalène utilisés pour le traitement de la douleur
WO2008130322A1 (fr) *	2007-04-23	2008-10-30	Astrazeneca Ab	Nouveaux dérivés 5-hétérocyclyl-chromane utilisés pour le traitement de la douleur
WO2008130321A2 (fr) *	2007-04-23	2008-10-30	Astrazeneca Ab	Nouveaux composés 807
SA08290245B1 (ar) *	2007-04-23	2012-02-12	استرازينيكا ايه بي	مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2047236C (fr)	1989-04-27	1997-07-22	Bengt Ronny Andersson	Derives de substitution de 3-aminochromanes
US5420151A (en) *	1989-12-22	1995-05-30	Aktiebolaget Astra	Chroman derivatives
SE8904361D0 (sv)	1989-12-22	1989-12-22	Astra Ab	New chroman and thiochroman derivatives
JPH11511156A (ja) *	1995-08-11	1999-09-28	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	ビフェニル（チオ）アミドおよびビフェニルエタン（チオ）オン誘導体、その製造方法ならびに５−ｈｔ▲下１ｄ▼ 受容体拮抗薬としてのその使用

1997
- 1997-09-18 SE SE9703378A patent/SE9703378D0/xx unknown
1998
- 1998-08-27 ZA ZA987806A patent/ZA987806B/xx unknown
- 1998-09-09 HU HU0100276A patent/HUP0100276A3/hu unknown
- 1998-09-09 AT AT98944378T patent/ATE255099T1/de not_active IP Right Cessation
- 1998-09-09 HR HR20000133A patent/HRP20000133A2/hr not_active Application Discontinuation
- 1998-09-09 CN CN98811095A patent/CN1278809A/zh active Pending
- 1998-09-09 EP EP98944378A patent/EP1025096B1/fr not_active Expired - Lifetime
- 1998-09-09 EE EEP200000144A patent/EE200000144A/xx unknown
- 1998-09-09 US US09/171,572 patent/US6387899B1/en not_active Expired - Fee Related
- 1998-09-09 TR TR2000/00737T patent/TR200000737T2/xx unknown
- 1998-09-09 IL IL13507498A patent/IL135074A0/xx unknown
- 1998-09-09 JP JP2000511762A patent/JP4002392B2/ja not_active Expired - Fee Related
- 1998-09-09 WO PCT/SE1998/001604 patent/WO1999014213A1/fr not_active Ceased
- 1998-09-09 AU AU91933/98A patent/AU9193398A/en not_active Abandoned
- 1998-09-09 SK SK287-2000A patent/SK2872000A3/sk unknown
- 1998-09-09 KR KR1020007002824A patent/KR20010024078A/ko not_active Withdrawn
- 1998-09-09 BR BR9812239-8A patent/BR9812239A/pt not_active IP Right Cessation
- 1998-09-09 PL PL98339661A patent/PL339661A1/xx not_active Application Discontinuation
- 1998-09-09 CA CA002303926A patent/CA2303926A1/fr not_active Abandoned
- 1998-09-09 DE DE69820103T patent/DE69820103T2/de not_active Expired - Fee Related
- 1998-09-17 AR ARP980104637A patent/AR016651A1/es not_active Application Discontinuation
2000
- 2000-03-14 IS IS5403A patent/IS5403A/is unknown
- 2000-03-17 NO NO20001403A patent/NO20001403L/no not_active Application Discontinuation
- 2000-08-31 US US09/653,552 patent/US6384225B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP0100276A2 (hu)	2002-05-29
IS5403A (is)	2000-03-14
CA2303926A1 (fr)	1999-03-25
IL135074A0 (en)	2001-05-20
KR20010024078A (ko)	2001-03-26
NO20001403D0 (no)	2000-03-17
EE200000144A (et)	2001-02-15
JP4002392B2 (ja)	2007-10-31
HRP20000133A2 (en)	2001-12-31
ATE255099T1 (de)	2003-12-15
TR200000737T2 (tr)	2000-09-21
US6384225B1 (en)	2002-05-07
SE9703378D0 (sv)	1997-09-18
CN1278809A (zh)	2001-01-03
WO1999014213A1 (fr)	1999-03-25
DE69820103D1 (de)	2004-01-08
PL339661A1 (en)	2001-01-02
HUP0100276A3 (en)	2002-08-28
JP2001516755A (ja)	2001-10-02
ZA987806B (en)	1999-03-18
EP1025096B1 (fr)	2003-11-26
AU9193398A (en)	1999-04-05
AR016651A1 (es)	2001-07-25
BR9812239A (pt)	2000-07-18
DE69820103T2 (de)	2004-09-02
EP1025096A1 (fr)	2000-08-09
SK2872000A3 (en)	2000-11-07
US6387899B1 (en)	2002-05-14

Legal Events

Date	Code	Title	Description
2003-06-10	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20001403L (no)	2000-05-18	Substituerte kromanderivater
SE9702799D0 (sv)	1997-07-25	New compounds
NO20001402L (no)	2000-05-09	Substituerte kromanderivater
CA2674548A1 (fr)	2008-07-03	Nouveau derive n-(2-aminophenyl)benzamide presentant une structure d'uree
NO20055316L (no)	2006-01-11	Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike
YU40998A (sh)	1999-09-27	Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
DE69633607D1 (de)	2004-11-18	Piperidinderivate mit tachykinin-antagonistischer wirkung
HRP20070430T3 (en)	2007-11-30	(3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
NO20061419L (no)	2006-07-14	Triaza-spiropiperidinderivater for anvendelse som Glyt-1-inhibitorer i behandling av nevrologiske og nevropsykiatriske lidelser
AR049739A1 (es)	2006-08-30	Derivados de aril-piridina
PE20010482A1 (es)	2001-04-20	Derivados de 3-ureido-pirazol y procedimiento para su preparacion
JP2016524597A (ja)	2016-08-18	選択的ヒストン脱アセチル化酵素抑制剤としての新規化合物およびこれを含む薬剤学的組成物
BG105271A (bg)	2001-11-30	Производни на 1h-имидазопиридин
CO5570669A2 (es)	2005-10-31	Pirazolopirimidinas como agentes terapeuticos
NO990551L (no)	1999-04-07	Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
RU2005113153A (ru)	2006-11-10	Новые пиримидинамидные производные и их применение
SE0101579D0 (sv)	2001-05-04	New compounds
PT1216245E (pt)	2004-08-31	Derivados sulfonil-hidrazida farmaceuticamente activos
KR890001957A (ko)	1989-04-06	N-아미노부틸-n-페닐아릴아미드 유도체, 그의 제법 및 치료에의 응용
RU2008145597A (ru)	2010-05-27	Гетероциклические арилсульфоны, пригодные для лечения расстройств, которые отвечают на модулирование 5-ht6 рецепторов
AR041376A1 (es)	2005-05-11	Piperazinas sustituidas por heterociclos para el tratamiento de la esquizofrenia
NO994340L (no)	1999-09-07	FremgangsmÕte for fremstilling av 2-[[(2-pyridinyl)metyl]sulfinyl]-1H-benzimidazoler samt nye forbindelser til anvendelse for dette formÕl
CO5720994A2 (es)	2007-01-31	Derivados sustituidos del pirrol
EA200001009A1 (ru)	2001-02-26	Производные пиридина, ингибирующие фосфодиэстеразу iv
NO20070972L (no)	2007-02-28	Benzyloksyderivater som MAOB-inhibitorer